Back

The signal peptide of CNP is a novel predictor of MI, MACE and bleeding risk in chest pain patients

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Clinical risk factors, prevalence and prognosis Biomarkers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Chris Pemberton

University of Otago Christchurch, Christchurch (New Zealand)

13 More presentations in this session

Presentation thumbnail
Identification of patients at extremely-high cardiovascular risk within a very-high risk population from the TERCET Registry.
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides
Presentation thumbnail
Risk Or Benefit IN Screening for CArdiovascular disease (ROBINSCA): results from screening for a high cardiovascular disease risk by using a risk prediction model or coronary artery calcium scoring
Professor H. de Koning (Rotterdam, NL)
Abstract
Presentation thumbnail
Cystatin C based eGFR estimation compared to crea-based estimation equation for assessing risk of cardiovascular and total mortality in population-based studies and patients with manifest CVD
Professor W. Koenig (Munich, DE)
Abstract
Presentation thumbnail
Influence of TCF21 rs12190287 in the coronary artery disease risk prediction. An association study in a Portuguese population.
Doctor J. Sousa (Funchal, PT)
Abstract Slides
Presentation thumbnail
Definition of extremely high cardiovascular risk in patients after acute myocardial infarction - Data from the TERCET Registry.
Associate Professor K. Dyrbus (Zabrze, PL)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 4 - Clinical risk factors, prevalence and prognosis

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers
thumbnail
Webinar
Biomarkers of clinical utility in cardiovascular disease
thumbnail
Congress Session
Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources